Stocks fell sharply on Thursday as U.S.-China trade worries persisted with more companies suspending business with Chinese telecom giant Huawei.Marketsread more
The yield on the 10-year Treasury note fell to its lowest level since 2017 as more traders grew confident in a longer U.S.-China conflict.Bondsread more
A Ministry of Commerce spokesperson does not single out any U.S. action, but it's been a tense couple of weeks for the trade war.World Politicsread more
In a four-page letter sent Thursday morning, Warren and Ocasio-Cortez asked Mnuchin a series of questions about his advisory role in former Sears CEO Eddie Lampert's...Politicsread more
"For them to say that they don't work with the Chinese government is false," Secretary of State Mike Pompeo tells CNBC.Politicsread more
Facebook has stopped paying commission to staff for selling political advertisements on its platform, The Wall Street Journal reported.Technologyread more
Prosecutors allege that Stephen Calk, former president of Chicago-based Federal Savings Bank, loaned former Trump campaign chair Paul Manafort as much as $16 million in...Politicsread more
Oil prices tumble as the market braces for a prolonged U.S.-China trade war and on signs the U.S. is willing to negotiate with Iran.Energy Commoditiesread more
U.S. manufacturer growth hit new lows in May, the latest sign that the economic slowdown accelerated amid the ongoing trade war.Economyread more
Wall Street is under pressure, but a handful of stocks are breaking out to new highs. McDonald's, Waste Management, Hershey, Visa and Costco have notched records this month,...Trading Nationread more
In its 35-year history, Dell has grown from a PC maker to a technology conglomerate with $90 billion in revenue and services in storage, servers, cloud infrastructure and data...Technologyread more
Johnson & Johnson said Thursday it will start giving the list price of its prescription drugs in television ads.
The company would be the first drugmaker to take that step.
The health care giant will begin with its popular blood thinner, Xarelto, said Scott White, head of J&J's North American pharmaceutical marketing. By late March, commercials will give the pill's list price plus typical out-of-pocket costs. The information will appear on screen at the end of the commercial and include a website where people can enter insurance information to get more specific costs.
Without insurance, Xarelto costs $450 to $540 per month, depending on the pharmacy. About 1 million Xarelto prescriptions are filled in the U.S. each month.
J&J's move comes amid growing scrutiny of soaring brand-name drug prices — and follows a Trump administration proposal to require list prices in TV ads. The pharmaceutical industry opposes that, arguing few people pay the high list prices. Some people's out-of-pocket costs, though, are based on list prices.
The main drugmaker trade group instead recommends TV ads start listing a website that gives possible out-of-pocket costs and list prices. Last month, Eli Lilly started doing so, in ads for diabetes medicine Trulicity.